发明名称 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone
摘要 The presence of the ancient anti-inflammatory peptide alpha-melanocyte stimulating hormone (alpha-MSH [1-13], SYSMEHFRWGKPV) in barrier organs such as gut and skin suggests a role in the nonspecific (innate) host defense system. alpha-MSH and other amino acid sequences derived from alpha-MSH were determined to have antimicrobial influences, including against two major and representative cutaneous and mucosal pathogens: Staphylococcus aureus and Candida albicans. alpha-MSH peptides had antimicrobial effects against S. aureus and significantly reversed the enhancing effect of urokinase on S. aureus colony formation. alpha-MSH and other amino acid sequences reduced C. albicans viability and germination. alpha-MSH peptides also enhanced C. albicans killing by human neutrophils. The antimicrobial agent is selected from the group consisting of one or more peptides including the amino acid sequence KPV, one or more peptides including the amino acid sequence MEHFRWG, or a biologically functional equivalent of any of the foregoing. The most effective of the peptides were those bearing the C-terminal amino acid sequence of alpha-MSH, i.e., alpha-MSH (1-13), (6-13), and (11-13). The alpha-MSH "core" sequence (4-10), important for melanotropic effects, was also effective but significantly less potent. Antimicrobial influences of alpha-MSH peptides could be mediated by their well-known capacity to increase cellular cAMP; this messenger was significantly augmented in peptide-treated yeast. alpha-MSH has potent anti-inflammatory effects and is expected to be useful for treatment of inflammation in human and veterinary disorders. Reduced killing of pathogens is a detrimental consequence of therapy with corticosteroids and nonsteroidal anti-inflammatory drugs during infection. Therefore, anti-inflammatory agents based on alpha-MSH peptides that do not reduce microbial killing, but rather enhance it, would be very useful. The antimicrobial effects of these alpha-MSH peptides occurred over a broad range of concentrations including the physiological (picomolar) range.
申请公布号 US2002137685(A1) 申请公布日期 2002.09.26
申请号 US20010957765 申请日期 2001.09.21
申请人 ZENGEN, INC. 发明人 CATANIA ANNA PIA;LIPTON JAMES M.
分类号 A61K9/00;A61K38/07;A61K38/34;(IPC1-7):A61K38/08;A61K38/06 主分类号 A61K9/00
代理机构 代理人
主权项
地址